EUVIMEDEUVIMED entdecken
Open Access

Mechanisms of VEGFR2 activation by VEGF, neuropilin, and heparin

Lianqi Chen iD, Zhichen Sun iD, Jian Qiao iD, Xiao-Chen Bai iD, Xuewu Zhang iD

Science Advances · 2026

DOI: 10.1126/sciadv.aeg6323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Lianqi Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-2, Heparin, Vascular Endothelial Growth Factor A, Neuropilins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular endothelial growth factor (VEGF) and its receptor VEGFR are master regulators of vasculogenesis and angiogenesis. VEGF activates VEGFR by inducing its dimerization and trans-autophosphorylation. The coreceptor neuropilin (Nrp1 and Nrp2) and heparan sulfate proteoglycan (HSPG) modulate VEGF-VEGFR signaling, but the underlying mechanisms remain incompletely understood. Here we report a cryo-EM structure of the dimeric mouse VEGF 164 -VEGFR2-Nrp1 ectodomain complex with a 2:2:2 stoichiometry, revealing direct Nrp1-VEGFR2 interactions that stabilize the VEGFR2 dimer. We also determined two cryo-EM structures of the VEGF 164 -VEGFR2-Nrp1 complex in the presence of short- or long-chain heparin, which bridges all three proteins and promotes the formation of two distinct tetrameric complexes. Long-chain heparin induces a cis tetrameric complex consistent with receptor clustering on the same cell surface, whereas short-chain heparin promotes a trans tetrameric assembly which might be formed by two dimeric complexes from opposing cells. Our structure-based mutational analyses support the model that both the Nrp1-VEGFR2 interface and the heparin-mediated clustering enhance VEGFR2 signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor Receptor-2HeparinVascular Endothelial Growth Factor ANeuropilinsNeuropilin-1AnimalsMiceCryoelectron MicroscopyProtein BindingSignal TransductionProtein MultimerizationModels, MolecularHumans

Substanzen

Vascular Endothelial Growth Factor Receptor-2HeparinVascular Endothelial Growth Factor ANeuropilinsNeuropilin-1Kdr protein, mouse

Autor:innen und Institutionen

  • Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

ORCID-Profile: Lianqi Chen, Zhichen Sun, Jian Qiao, Xiao-Chen Bai, Xuewu Zhang

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • Welch Foundation
  • Cancer Prevention and Research Institute of Texas
  • University of Texas Southwestern Medical Center

Zitieren

APA

Chen, L., Sun, Z., Qiao, J., Bai, X. C., & Zhang, X. (2026). Mechanisms of VEGFR2 activation by VEGF, neuropilin, and heparin. Science Advances. https://doi.org/10.1126/sciadv.aeg6323

Vancouver

Chen L, Sun Z, Qiao J, Bai XC, Zhang X. Mechanisms of VEGFR2 activation by VEGF, neuropilin, and heparin. Science Advances. 2026. doi:10.1126/sciadv.aeg6323

BibTeX
@article{Chen2026,
  author = {Chen, Lianqi and Sun, Zhichen and Qiao, Jian and Bai, Xiao-Chen and Zhang, Xuewu},
  title = {Mechanisms of VEGFR2 activation by VEGF, neuropilin, and heparin},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aeg6323}
}
Kostenlos starten →